analyst day reaffirm posit
view rais estim
net dbt
upbeat analyst day posit updat yr plan
comment healthcar conf link expect rais expect
reiter outlook focu next guid futur capit
deploy compani abil leverag increas breadth product
servic point deliv out-year ep target ahead est
see preview link specif still see organ growth
target back upsid well annual op
margin expans rais capit deploy outlook
time period share buyback dividend result
adj ep mdpt compound-annual-growth-rate vs prior
compound-annual-growth-rate street consensu
remain core lst hold top pick tool
thesi continu see better core growth given scale
geograph reach share gain portfolio breadth innov given broad strength
end-market recent high growth deal annual begin contribut
organ growth addit expand vs prior due
beachhead patheon acquisit link contract develop
manufactur organ space help off-set critic run
inorgan opportun continu opportun expans high growth
market china leverag channel busi reaffirm view
still long runway continu view core hold
investor look solid secular growth reason price
rais po reiter buy
highlight preview improv earn outlook highlight
conserv natur street ep est impli adj ep
midpnt street adj ep
midpnt street maintain ep estimate rais
out-year sale ep forecast updat outlook driven part higher
forecast rais po still base wacc
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
thermo fisher scientif largest
consist analyt instrument lab
equip consum softwar servic
use throughout research drug manufactur
diagnost food consum product safeti
environment test
thermo fisher scientif largest life scienc
tool compani think recent acquisit
complementari technolog higher growth
on-going process improv initi
expand footprint emerg appli
market help grow revenu steadili
line even modestli better
overal tool market deliv low teen ep
compound-annual-growth-rate next sever year
addit color financi outlook
reiter prior organ growth guid well guid
believ figur upsid due strong end-market favor busi
condit upsid recent deal feic pthn
tmo adjust opm expect expand annual result
opm
adjust ep expect grow annual
impli ep midpoint street
impli adj ep midpoint consensu
expect convert adjust net incom free
vs prior outlook like due larger capital-expenditure requir patheon
adjust expect grow compound-annual-growth-rate vs prior
expect deploy capit bolt-on
share buybacks/dividend per year
increas last year outlook
still expect maintain target gross leverag ratio end
year unchang tmo net debt/adjust ttm ebitda leverag end
elev due patheon acquisit
expect tax-rat last year analyst day guid
higher our-year organ revenu expect well ad growth
 rais sale estim
rais non-gaap ep estim
higher revenu growth assum higher level share buyback
po base dcf model assum wacc termin
growth rate impli multipl approxim ep estim in-lin
compani peer group averag given size market leadership matur
stabil compani consum focus busi believ dcf
appropri way valu compani risk price object deal
integr risk lower-than-expect deal synergi slower growth emerg
market price eros lower healthcar util trend soft uptak new
product competit weak fund
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
becton dickinson compani
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
